Carisma Therapeutics, OrthoCellix enter definitive merger agreement

finance.yahoo.com/news/carisma-therapeutics-orthocellix-enter-definitive-170730972.html

In This Article:
Carisma Therapeutics (CARM) and OrthoCellix, a wholly-owned subsidiary of Ocugen (OCGN), announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on the development of…

This story appeared on finance.yahoo.com, 2025-06-24 17:07:30.
The Entire Business World on a Single Page. Free to Use →